Jazz Pharmaceuticals to Acquire Cannabis Drug Company

Jazz Pharmaceuticals (NASDAQ: JAZZ) announced a $7.6 billion deal to acquire GW Pharmaceuticals (NASDAQ: GWPH), a British biotech company focused on drugs derived from cannabis. The unexpected news sent shares of GW Pharmaceuticals soaring 46%.Under the terms of the agreement, JaRead MoreMarketsMarkets Feed